DCDR Spectroscopy for HbA1c Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting glycated hemoglobin (HbA1c) face challenges such as poor spectral reproducibility and interference from hemoglobin variants, limiting their effectiveness in diabetes management.
Innovation Solution
The use of drop coating deposition Raman (DCDR) spectroscopy for selective detection of HbA1c, combined with multimodal imaging, provides concentrated samples for accurate Raman measurements, enabling precise quantification and classification of glycated and unglycated hemoglobin through multivariate techniques.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If surface enhanced resonance Raman spectroscopy (SERRS) is used for HbA1c detection, then sensitivity is improved, but spectral reproducibility deteriorates and spurious background signals are generated
Solution Approach 1:
The invention extracts and removes the problematic enhancement step from the detection process. By eliminating the surface enhancement component (silver nanoparticles) while retaining conventional Raman spectroscopy, the method achieves spectral reproducibility without the spurious background signals that plague SERRS approaches.
Solution Approach 2:
The invention performs preliminary concentration of HbA1c and other analytes through drop coating deposition before Raman measurement. This pre-concentration step, which creates a coffee-ring pattern, provides sufficient signal intensity without requiring surface enhancement, thereby ensuring both sensitivity and spectral reproducibility.
2Reliability
If conventional Raman spectroscopy is used for HbA1c detection, then spectral reproducibility is maintained, but detection sensitivity deteriorates due to low analyte concentration
Solution Approach 1:
The invention performs preliminary concentration of dilute analytes through the drop coating deposition process. As the solvent evaporates, analytes are concentrated at the contact line forming a coffee-ring pattern, providing sufficient signal intensity for conventional Raman spectroscopy to detect HbA1c at physiologically relevant concentrations.
Solution Approach 2:
The invention changes the concentration parameter of the analyte by utilizing the natural evaporation and capillary flow processes in drop coating. This transforms dilute samples into concentrated deposits at the contact line, enabling detection without surface enhancement while maintaining spectral reproducibility.
3Adaptability or versatility
If hemoglobin variants are present in the sample, then clinical complexity increases, but HbA1c detection accuracy deteriorates due to interference
Solution Approach 1:
The invention segments the complex blood sample into individual molecular components through Raman spectroscopy. By analyzing the unique vibrational spectra of HbA1c, hemoglobin variants, and other blood constituents separately, the method can distinguish and quantify HbA1c even in the presence of interfering variants, providing accurate measurements in clinically complex samples.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach offers high reproducibility, linearity, and sensitivity, allowing for accurate detection of HbA1c at lower concentrations and in complex mixtures, complementing existing analytical techniques for improved glycemic control.
Implementation Method 1
Raman spectroscopy for detection of glycated analytes
Implementation Method 2
spectra are acquired from the ring pattern of analytes deposited from a drying drop, which is a formed as a result of the interplay of contact line pinning, solvent evaporation and capillary flow
Implementation Method 3
spectra are acquired from the ring pattern of analytes deposited from a drying drop, which is a formed as a result of the interplay of contact line pinning, solvent evaporation and capillary flow
Data Source
AI summary
The present invention relates to the optical measurement of blood analytes, such as glycated hemoglobin (HbA1c) and serum albumin as a functional metric of mean blood glucose in the diagnosis of diabetic patients. Non-enhanced Raman spectroscopy is employed as the analytical method for quantitative detection of blood analytes. Using processing techniques, non-enzymatic glycosylation (glycation) of the analytes results in measurable and highly reproducible changes in the acquired spectral data, which enable the accurate measurements and classification of glycated and unglycated analytes.